The emerging role of peptidyl‐prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1471-4159|133|1|1-13

ISSN： 0022-3042

Source： JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol.133, Iss.1, 2015-04, pp. : 1-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease

By Lai Robert Y. K.   Harrington Charles R.   Wischik Claude M.  

Biomolecules, Vol. 6, Iss. 2, 2016-04 ,pp. : 19-19

MDPI

Access to resources Recommend Favorite

Nuclear Tau and Its Potential Role in Alzheimer’s Disease

By Bukar Maina Mahmoud   Al-Hilaly Youssra K.   Serpell Louise C.  

Biomolecules, Vol. 6, Iss. 1, 2016-01 ,pp. : 9-9

MDPI

Access to resources Recommend Favorite

FK506-Binding Protein 22 from a Psychrophilic Bacterium, a Cold Shock-Inducible Peptidyl Prolyl Isomerase with the Ability to Assist in Protein Folding

By Budiman Cahyo   Koga Yuichi   Takano Kazufumi   Kanaya Shigenori  

International Journal of Molecular Sciences, Vol. 12, Iss. 8, 2011-08 ,pp. : 5261-5284

MDPI

Access to resources Recommend Favorite

Potential Natural Products for Alzheimer’s Disease: Targeted Search Using the Internal Ribosome Entry Site of Tau and Amyloid-β Precursor Protein

By Tasi Yun-Chieh   Chin Ting-Yu   Chen Ying-Ju   Huang Chun-Chih   Lee Shou-Lun   Wu Tzong-Yuan  

International Journal of Molecular Sciences, Vol. 16, Iss. 4, 2015-04 ,pp. : 8789-8810

MDPI

Access to resources Recommend Favorite

A novel DYRK1A (Dual specificity tyrosine phosphorylation‐regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 133, Iss. 3, 2015-05 ,pp. : 440-451

John Wiley & Sons Inc

Access to resources Recommend Favorite